Overview

A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This pilot study is designed to explore the optimal concentration and method of Ginkgolides Meglumine Injection skin testing and to evaluate the value of skin test in predicting any possible allergic reactions to Ginkgolides Meglumine Injection.
Phase:
Phase 4
Details
Lead Sponsor:
Jiangsu Kanion Pharmaceutical Co., Ltd
Collaborator:
Beijing Bionovo Medicine Development Co., Ltd.